Want to see SG:BTOU full AI Analyst Report?
Top Page
Manulife US REIT
(SGX:BTOU)
Select Model
Select Model
Rating:43Neutral
Price Target:
$0.05
▼(-28.57% Downside)
Action:Reiterated
Date:04/25/26
The score is driven primarily by weak financial performance (sharp revenue decline and persistent losses, with weakening free cash flow), which outweighs the benefit of still-positive operating cash flow and some debt reduction. Technicals add mild pressure as the stock trades below major moving averages with negative MACD, while valuation is difficult to support given negative earnings and no dividend yield data.
Positive Factors
Operating Cash Flow
Consistent positive operating cash flow indicates the core property portfolio still generates cash from leasing activity despite accounting losses. This cash underpinning supports routine distributions, capital maintenance, and servicing of debt, making short-to-medium term operations more resilient.
Negative Factors
Sharp Revenue Contraction
A near-term structural decline in rental revenue signals worsening leasing outcomes or asset disposals. Persistently declining top-line reduces margins and distributable income, making recovery dependent on sustained demand improvement or successful portfolio repositioning over multiple quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating Cash Flow
Consistent positive operating cash flow indicates the core property portfolio still generates cash from leasing activity despite accounting losses. This cash underpinning supports routine distributions, capital maintenance, and servicing of debt, making short-to-medium term operations more resilient.
Read all positive factors
Manulife US REIT (BTOU) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
$92.38M
Dividend YieldN/A
Average Volume (3M)5.37M
Price to Earnings (P/E)―
Beta (1Y)1.17
Revenue Growth-32.02%
EPS Growth55.49%
CountrySG
Employees16
SectorReal Estate
Sector Strength53
IndustryREIT - Office
Share Statistics
EPS (TTM)-0.04
Shares Outstanding1,776,565,400
10 Day Avg. Volume1,731,870
30 Day Avg. Volume5,368,633
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.46
Price to Sales (P/S)1.45
P/FCF Ratio19.72
Enterprise Value/Market Cap6.65
Enterprise Value/Revenue5.40
Enterprise Value/Gross Profit12.21
Enterprise Value/Ebitda10.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)$100.60M
Manulife US REIT Business Overview & Revenue Model
Company Description
Manulife US Real Estate Investment Trust (Manulife US REIT) holds the distinction of being the first dedicated US office real estate investment trust to be listed on an Asian exchange. As a REIT traded in Singapore, its core investment mandate inv...
How the Company Makes Money
Manulife US REIT generates income primarily from rental revenue earned by leasing space in its U.S. office properties to tenants under commercial lease agreements. Tenants typically pay base rent, and depending on lease structure, may also reimbur...
Manulife US REIT Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
44
Neutral
Cash Flow
52
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 87.18M | 167.58M | 208.03M | 202.56M | 185.10M |
| Gross Profit | 31.13M | 72.85M | 106.77M | 113.16M | 100.99M |
| EBITDA | -24.57M | -129.47M | 96.23M | -111.76M | 114.04M |
| Net Income | -61.88M | -178.00M | -379.96M | -129.72M | 39.41M |
Balance Sheet | |||||
| Total Assets | 749.00M | 1.22B | 1.59B | 2.12B | 2.28B |
| Cash, Cash Equivalents and Short-Term Investments | 37.13M | 65.24M | 129.73M | 114.13M | 78.58M |
| Total Debt | 439.62M | 745.95M | 921.23M | 1.03B | 971.29M |
| Total Liabilities | 477.01M | 794.03M | 979.63M | 1.10B | 1.09B |
| Stockholders Equity | 271.99M | 430.63M | 608.63M | 1.02B | 1.19B |
Cash Flow | |||||
| Free Cash Flow | 6.40M | 7.87M | 32.35M | 66.57M | 60.65M |
| Operating Cash Flow | 24.51M | 48.50M | 76.82M | 91.99M | 90.63M |
| Investing Cash Flow | 137.40M | 70.44M | 86.58M | -25.37M | -230.93M |
| Financing Cash Flow | -180.32M | -176.07M | -171.57M | -32.37M | 132.22M |
Manulife US REIT Technical Analysis
Negative
0.07
Price Trends
0.05
Negative
0.06
Negative
0.07
Negative
Market Momentum
>-0.01
Negative
38.68
Neutral
-50.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:BTOU, the sentiment is Negative. The current price of 0.07 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.07, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 38.68 is Neutral, neither overbought nor oversold. The STOCH value of -50.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:BTOU.
Manulife US REIT Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | $316.25M | 14.88 | 4.67% | 8.23% | -1.69% | -32.49% | |
63 Neutral | £197.31M | 0.13 | 5.84% | 8.36% | -1.97% | -34.76% | |
56 Neutral | $228.56M | 10.40 | 2.75% | 2.40% | -5.79% | 143.55% | |
51 Neutral | $185.91M | -44.25 | -0.27% | ― | 2.57% | 40.91% | |
50 Neutral | $121.82M | -4.61 | -6.69% | 5.06% | -5.96% | -13.94% | |
43 Neutral | $92.38M | -1.09 | -37.68% | ― | -32.02% | 55.49% |
* Real Estate Sector Average
SG:BTOU
Manulife US REIT
0.05
-0.02
-23.53%
SG:OXMU
Prime US REIT
0.16
>-0.01
-3.70%
SG:XZL
ARA US Hospitality Trust
0.22
-0.06
-20.66%
SG:CMOU
Kore US Reit
0.18
-0.04
-16.51%
SG:MXNU
Elite UK REIT
31.00
1.25
4.18%
SG:ODBU
United Hampshire US Real Estate Investment Trust
0.52
0.09
20.61%
Manulife US REIT Corporate Events
Manulife US REIT Redeems Preferred Shares After Figueroa Property Divestment
Jun 30, 2026
Manulife US REIT has completed the redemption of all 115 preferred shares in its indirect subsidiary Hancock S-REIT LA Corp., which previously held the Figueroa office property in Los Angeles that was divested earlier this year. The US$0.1 million...
Manulife US REIT Confirms No U.S. Withholding Tax on Unit Transfers
Jun 26, 2026
Manulife US Real Estate Investment Trust has confirmed that recent U.S. tax rules under Section 1446(f) will not trigger withholding tax on transfers of its units by non-U.S. investors. The trust has been structured so it is not engaged in a U.S. ...
Manulife US REIT refreshes board with director change and new appointment
Jun 2, 2026
Manulife US REIT has announced that Independent Non-Executive Director Dr Choo Kian Koon will retire from the board and the Nominating and Remuneration Committee on 8 June 2026, upon reaching the nine-year independence limit set by Singapore Excha...
Manulife US REIT unitholders back FY2025 accounts and unit issuance mandate at AGM
May 28, 2026
Manulife US REIT held its annual general meeting in Singapore on 29 April 2026, with the board, management team, trustees, auditors and legal advisers in attendance alongside unitholders. The CEO and CIO presented the trust’s FY2025 performa...
Manulife US REIT Boosts Balance Sheet With Figueroa Sale as Leasing Holds Steady
May 6, 2026
Manulife US REIT reported first-quarter 2026 portfolio occupancy of 67.6% and a weighted average lease expiry of 4.7 years, with 141,000 square feet of leases signed at slightly positive rent reversions. The trust continues to benefit from a diver...
Manulife US REIT Posts Weaker 2025 Results as It Sells LA Tower to Cut Debt
Apr 21, 2026
Manulife US REIT reported weaker FY 2025 financials as gross revenue and net property income fell sharply, driven by the disposal of several office assets and higher vacancies at key properties such as Diablo and Figueroa. Same-store portfolio NPI...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.